Antimicrobial activity against strains of Escherichia coli and Klebsiella spp. with resistance phenotypes consistent with an extended-spectrum β-lactamase in Europe
- 1 July 2003
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 9 (7) , 708-712
- https://doi.org/10.1046/j.1469-0691.2003.00555.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Increasing threat of Gram-negative bacteriaCritical Care Medicine, 2001
- Detection of emerging resistance patterns within longitudinal surveillance systems: data sensitivity and microbial susceptibilityJournal of Antimicrobial Chemotherapy, 2000
- MYSTIC (Meropenem Yearly Susceptibility Test Information Collection): a global overview.Journal of Antimicrobial Chemotherapy, 2000
- Surveillance studies: how can they help the management of infection?Journal of Antimicrobial Chemotherapy, 2000
- Are SHV β-Lactamases Universal in Klebsiella pneumoniae ? Antimicrobial Agents and Chemotherapy, 2000
- Toward multinational antimicrobial resistance surveillance systems in EuropeInternational Journal of Antimicrobial Agents, 2000
- Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997–1998Journal of Antimicrobial Chemotherapy, 2000
- The MYSTIC (meropenem yearly susceptibility test information collection) programmeInternational Journal of Antimicrobial Agents, 1999
- Evolution and Dissemination of β-Lactamases Accelerated by Generations of β-Lactam AntibioticsClinical Infectious Diseases, 1997
- Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States I. Study on the threat of emerging resistances: Real or perceived?Diagnostic Microbiology and Infectious Disease, 1994